{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:14:23Z","timestamp":1792088063739,"version":"4.4.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.critrevonc.2023.104055","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T22:14:23Z","timestamp":1686262463000},"page":"104055","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Special features of sarcomas developed in patients with Lynch syndrome: A systematic review"],"prefix":"10.1016","volume":"188","author":[{"given":"Fran\u00e7ois","family":"Poumeaud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaud","family":"Valentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Vande Perre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Jaffrelot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Chibon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Chevreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janick","family":"Selves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosine","family":"Guimbaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadim","family":"Fares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2023.104055_bib1","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00432-007-0220-2","article-title":"Microsatellite instability in Ewing tumor is not associated with loss of mismatch repair protein expression","volume":"133","author":"Alldinger","year":"2007","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2023.104055_bib2","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S1470-2045(16)30147-4","article-title":"Monogenic and polygenic determinants of sarcoma risk: an international genetic study","volume":"17","author":"Ballinger","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2023.104055_bib3","first-page":"5248","article-title":"A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer","volume":"58","author":"Boland","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2023.104055_bib4","doi-asserted-by":"crossref","first-page":"142","DOI":"10.11604\/pamj.2016.24.142.4398","article-title":"Syndrome de Lynch: \u00e0 propos d\u2019un cas et revue de la litterature","volume":"24","author":"Bouguenouch","year":"2016","journal-title":"Pan Afr. Med. J."},{"key":"10.1016\/j.critrevonc.2023.104055_bib5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.33590\/emj\/10313115","article-title":"The heart of the matter: a unique convergence of cardiac neoplasm, hereditary nonpolyposis colorectal cancer, and spindle cell sarcoma","volume":"4","author":"Bryer","year":"2019","journal-title":"Eur. Med. J."},{"key":"10.1016\/j.critrevonc.2023.104055_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12071848","article-title":"Clinical and molecular assessment of patients with lynch syndrome and sarcomas underpinning the association with MSH2 germline pathogenic variants","volume":"12","author":"de Angelis de Carvalho","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2023.104055_bib7","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ijc.33214","article-title":"Analysis in the Prospective Lynch Syndrome Database identifies sarcoma as part of the Lynch syndrome tumor spectrum","volume":"148","author":"Dominguez-Valentin","year":"2021","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.critrevonc.2023.104055_bib8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41436-019-0596-9","article-title":"Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database","volume":"22","author":"Dominguez-Valentin","year":"2020","journal-title":"Genet. Med."},{"key":"10.1016\/j.critrevonc.2023.104055_bib9","first-page":"977","article-title":"Characteristics of mismatch repair deficiency in sarcomas","volume":"32","author":"Doyle","year":"2019","journal-title":"Mod. Pathol. Off. J. U. S. Can. Acad. Pathol. Inc."},{"key":"10.1016\/j.critrevonc.2023.104055_bib10","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1200\/JCO.2016.71.9260","article-title":"Multigene panel testing provides a new perspective on lynch syndrome","volume":"35","author":"Espenschied","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2023.104055_bib11","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.3390\/cancers14174102","article-title":"Lynch syndrome: from carcinogenesis to prevention interventions","volume":"14","author":"Gambini","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2023.104055_bib12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41575-019-0126-x","article-title":"Immunotherapy in colorectal cancer: rationale, challenges and potential","volume":"16","author":"Ganesh","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.critrevonc.2023.104055_bib13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jviscsurg.2015.05.001","article-title":"Soft tissue sarcoma in France in 2015: epidemiology, classification and organization of clinical care","volume":"152","author":"Honor\u00e9","year":"2015","journal-title":"J. Visc. Surg."},{"key":"10.1016\/j.critrevonc.2023.104055_bib14","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3892\/ol.2012.885","article-title":"A case of multiple primary malignancies and investigation of family history","volume":"4","author":"Huang","year":"2012","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.critrevonc.2023.104055_bib15","first-page":"427","article-title":"An unusual phenotype occurs in 15 % of mismatch repair-deficient tumors and is associated with non-colorectal cancers and genetic syndromes","volume":"35","author":"Jaffrelot","year":"2022","journal-title":"Mod. Pathol. Off. J. U.S. Can. Acad. Pathol. Inc."},{"key":"10.1016\/j.critrevonc.2023.104055_bib16","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2015.33.15_suppl.1516","article-title":"Sarcoma: a Lynch syndrome (LS)-associated malignancy?","volume":"33","author":"Kaczmar","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2023.104055_bib17","article-title":"A novel founder MSH2 deletion in Ethiopian Jews is mainly associated with early-onset colorectal cancer","author":"Kedar","year":"2021","journal-title":"Fam. Cancer"},{"key":"10.1016\/j.critrevonc.2023.104055_bib18","doi-asserted-by":"crossref","DOI":"10.1111\/his.14377","article-title":"Mismatch repair deficiency is rare in bone and soft tissue tumors","author":"Lam","year":"2021","journal-title":"Histopathology"},{"key":"10.1016\/j.critrevonc.2023.104055_bib19","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1200\/JCO.18.00283","article-title":"MicrosatellitE Instability Is Associated with the Presence of Lynch Syndrome Pan-cancer","volume":"37","author":"Latham","year":"2019","journal-title":"J. Clin. Oncol. . J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2023.104055_bib20","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1093\/annonc\/mdz116","article-title":"ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1\/PD-L1 expression and tumour mutational burden: a systematic review-based approach","volume":"30","author":"Luchini","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2023.104055_bib21","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.1158\/1078-0432.CCR-21-0327","article-title":"FDA Approval Summary: pembrolizumab for the treatment of tumor mutational burden-high solid tumors","volume":"27","author":"Marcus","year":"2021","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.critrevonc.2023.104055_bib22","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1158\/1078-0432.CCR-18-4070","article-title":"FDA Approval Summary: pembrolizumab for the Treatment of Microsatellite Instability-High Solid Tumors","volume":"25","author":"Marcus","year":"2019","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.critrevonc.2023.104055_bib23","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/BF02303500","article-title":"Microsatellite instability in sarcomas","volume":"5","author":"Martin","year":"1998","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2023.104055_bib24","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.3390\/cancers14051115","article-title":"Lynch-like syndrome: potential mechanisms and management","volume":"14","author":"Mart\u00ednez-Roca","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2023.104055_bib25","article-title":"Trends of uterine carcinosarcoma in the United States","volume":"29","author":"Matsuo","year":"2018","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.critrevonc.2023.104055_bib26","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/annonc\/mdf163","article-title":"Highly aggressive leiomyosarcoma associated with Lynch II syndrome: increasing the range of extracolonic cancers related with hereditary non-polyposis colonic cancer","volume":"13","author":"Medina Arana","year":"2002","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"10.1016\/j.critrevonc.2023.104055_bib27","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13053-021-00192-z","article-title":"Myxofibrosarcoma harboring an MLH1 pathogenic germline variant associated with Muir-Torre syndrome: a case report","volume":"19","author":"Nakagawa","year":"2021","journal-title":"Hered. Cancer Clin. Pract."},{"key":"10.1016\/j.critrevonc.2023.104055_bib28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10689-008-9230-8","article-title":"Sarcomas associated with hereditary nonpolyposis colorectal cancer: broad anatomical and morphological spectrum","volume":"8","author":"Nilbert","year":"2009","journal-title":"Fam. Cancer"},{"key":"10.1016\/j.critrevonc.2023.104055_bib29","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cancergencyto.2003.08.014","article-title":"High frequency of genomic instability in Ewing family of tumors","volume":"150","author":"Ohali","year":"2004","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.critrevonc.2023.104055_bib30","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.critrevonc.2023.104055_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246958","article-title":"Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network","volume":"16","author":"Pinieux","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2023.104055_bib32","first-page":"405","article-title":"Standards and Guidelines for the Interpretation of Sequence Variants: a Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med. Off. J. Am. Coll. Med. Genet."},{"key":"10.1016\/j.critrevonc.2023.104055_bib33","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jmoldx.2010.11.011","article-title":"Frequency of deletions of EPCAM (TACSTD1) in MSH2-associated lynch syndrome cases","volume":"13","author":"Rumilla","year":"2011","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.critrevonc.2023.104055_bib34","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1001\/jamaoncol.2017.0619","article-title":"Association of mismatch repair mutation with age at cancer onset in lynch syndrome: implications for stratified surveillance strategies","volume":"3","author":"Ryan","year":"2017","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.critrevonc.2023.104055_bib35","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s12935-021-01976-y","article-title":"Mismatch repair-deficient hormone receptor-positive breast cancers: Biology and pathological characterization","volume":"21","author":"Sajjadi","year":"2021","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.critrevonc.2023.104055_bib36","doi-asserted-by":"crossref","first-page":"106","DOI":"10.5152\/ejbh.2020.5198","article-title":"Investigating the link between lynch syndrome and breast cancer","volume":"16","author":"Sheehan","year":"2020","journal-title":"Eur. J. Breast Health"},{"key":"10.1016\/j.critrevonc.2023.104055_bib37","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/pin.13020","article-title":"Primary intramucosal synovial sarcoma of the sigmoid colon in a patient with a germline mutation in the MSH2 gene: a case report","volume":"70","author":"Shigematsu","year":"2020","journal-title":"Pathol. Int."},{"key":"10.1016\/j.critrevonc.2023.104055_bib38","article-title":"Microsatellite instability profiles of gastrointestinal cancers: comparison between non-colorectal and colorectal origin","author":"Shinozaki-Ushiku","year":"2022","journal-title":"Histopathology"},{"key":"10.1016\/j.critrevonc.2023.104055_bib39","unstructured":"Soft-Tissue Tumors - ClinicalKey [WWW Document], n.d. URL https:\/\/www.clinicalkey.com\/#!\/content\/book\/3-s2.0-B9780323672177000286 (Accessed 4 April 2022)."},{"key":"10.1016\/j.critrevonc.2023.104055_bib40","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/jnci\/djm291","article-title":"The frequency of Muir-Torre syndrome among lynch syndrome families","volume":"100","author":"South","year":"2008","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"10.1016\/j.critrevonc.2023.104055_bib41","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bulcan.2018.12.008","article-title":"MSI\/MMR-deficient tumor diagnosis: which standard for screening and for diagnosis? Diagnostic modalities for the colon and other sites: differences between tumors","volume":"106","author":"Svrcek","year":"2019","journal-title":"Bull. Cancer"},{"key":"10.1016\/j.critrevonc.2023.104055_bib42","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s10147-019-01494-y","article-title":"Genetic and genomic basis of the mismatch repair system involved in Lynch syndrome","volume":"24","author":"Tamura","year":"2019","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2023.104055_bib43","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1002\/cncr.11326","article-title":"Reduced expression of hMSH2 protein is correlated to poor survival for soft tissue sarcoma patients","volume":"97","author":"Taubert","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2023.104055_bib44","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1136\/jmedgenet-2018-105594","article-title":"Chemoresistant pleomorphic rhabdomyosarcoma: whole exome sequencing reveals underlying cancer predisposition and therapeutic options","volume":"57","author":"Tlemsani","year":"2020","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.critrevonc.2023.104055_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41439-022-00185-x","article-title":"Pleomorphic rhabdomyosarcoma in a young adult harboring a novel germline MSH2 variant","volume":"9","author":"Tomida","year":"2022","journal-title":"Hum. Genome Var."},{"key":"10.1016\/j.critrevonc.2023.104055_bib46","doi-asserted-by":"crossref","first-page":"9307","DOI":"10.1007\/s11033-012-1729-2","article-title":"Soft tissue sarcoma and the hereditary non-polyposis colorectal cancer (HNPCC) syndrome: formulation of an hypothesis","volume":"39","author":"Urso","year":"2012","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.critrevonc.2023.104055_bib47","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00292-021-00935-8","article-title":"New in the current WHO classification (2020) for soft tissue sarcomas","volume":"42","author":"Wardelmann","year":"2021","journal-title":"Pathol"},{"key":"10.1016\/j.critrevonc.2023.104055_bib48","first-page":"6208029","article-title":"Primary pericardial sarcoma with right atrial invasion and multiple bilateral pulmonary metastases in a patient with hereditary nonpolyposis colorectal cancer","volume":"2016","author":"Wong","year":"2016","journal-title":"Case Rep. Oncol. Med."},{"key":"10.1016\/j.critrevonc.2023.104055_bib49","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00428-012-1369-x","article-title":"Muir-Torre syndrome-associated pleomorphic liposarcoma arising in a previous radiation field","volume":"462","author":"Yozu","year":"2013","journal-title":"Virchows Arch. Int. J. Pathol."},{"key":"10.1016\/j.critrevonc.2023.104055_bib50","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1200\/JCO.2016.71.0012","article-title":"Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer","volume":"35","author":"Yurgelun","year":"2017","journal-title":"J. Clin. Oncol. . J. Am. Soc. Clin. Oncol."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842823001439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842823001439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T19:49:02Z","timestamp":1760903342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842823001439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":50,"alternative-id":["S1040842823001439"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2023.104055","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Special features of sarcomas developed in patients with Lynch syndrome: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2023.104055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104055"}}